TCL Archive FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts October 9, 1981
TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship July 23, 1999
